A game of Whack-A-Mole: closing multiple ventricular septal defects
By their expert review of the existing literature on multiple
ventricular septal defects (m-VSD), Chowdhury and colleagues [1]
have described a systematic approach to this challenging clinical
problem. m-VSD can be onerous to manage. Besides the inability to close
all the defects in one operative setting due to inadequate
visualization, previously undetected defects may become clinically
apparent after the closure of the dominant defects, leading to
inadequate ventricular septation. This increases the morbidity from the
progression of pulmonary hypertension, persistence of congestive cardiac
failure, higher incidence of postoperative heart block, and the need for
reoperations. As alluded to in their manuscript, this can translate to
an overall increase in operative mortality compared to an isolated
perimembranous VSD.
The authors have nicely divided m-VSD into the following morphological
types: multiple discrete muscular defects, combined perimembranous and
inlet muscular septal defect, apical m-VSD, spurious m-VSD, and
Swiss-cheese defects. Classifying the defects into such morphological
types has a clinical bearing on these defects’ approach and closure
techniques.
While it is usual to start with conventional echocardiography to
characterize these defects, further valuable information can be obtained
with novel echocardiographic methods such as an “en-face” imaging of
the ventricular septum. Cross-sectional imaging with CT angiography can
help further delineate the defects and help with operative planning.
Similarly, 3-D printing can also add valuable information in some
instances [2].
The majority of these defects can be approached via a trans-tricuspid
approach, but certain defects such as apical m-VSD may require a
ventriculotomy [3]. Surgical techniques can involve the closure of
each defect to simultaneous coverage of multiple defects in proximity
with a large patch. At times, the defects may need to be obliterated
en-masse, especially when they are centered in the apical septum. Again,
understanding the morphology of the m-VSD can have critical implications
on surgical approaches and outcomes. The spurious m-VSD type, which has
multiple openings on the right ventricular side, has a single opening on
the left ventricular side and can be elegantly closed from that side. In
the combined perimembranous and inlet muscular septal defect type, the
conduction pathway is located between these defects and is in jeopardy
if incorporated in the repair.
Options also exist for using a septal occluder device in conjunction
with operative closure as a hybrid strategy. Such a technique may help
with the increased overall success of the procedure by facilitating
closure of difficult-to-reach defects by an open method, avoiding
additional incisions such as a ventriculotomy, thus preserving
ventricular function and helping decrease operative times. However,
septal occluder device should be used with caution, particularly in
small hearts, and when more than one occluder device is required, as it
can induce acute diastolic dysfunction by decreasing the ventricular
cavity size from overcrowding or by tethering the ventricular free wall
[4,5].
While the optimal goal of
ventricular septation would be no residual shunting and preservation of
both the systolic and diastolic ventricular function, this may not
always be attainable. Thus, an alternative goal would be to protect the
pulmonary vascular bed by pulmonary artery banding. Apart from
protecting the pulmonary vascular bed, PA banding facilitates closure of
some of the defects spontaneously, may help with better access to the
defects in the future by allowing for somatic growth of small hearts,
help abbreviate the operative procedure in cases where there are complex
associated cardiac defects, and help bail out when all hemodynamically
significant defects cannot be closed in one operative setting. Finally,
if the ventricular septum is not deemed septatable, such as in a Swiss
cheese type [3], protecting the pulmonary vascular bed may allow
pursuing a single ventricle pathway.
When possible, primary
definitive repair should be the goal, as it is associated with better
outcomes than PA banding with or without delayed closure of the m-VSD
defects [3,6]. Unfortunately, some of the m-VSD patients have or
acquire severe ventricular dysfunction after repair and may need cardiac
transplantation.
- Chowdhury U, Anderson R, Spicer D E et al. A review of the therapeutic
management of multiple ventricular septal defects. J Card Surg; in
press
- Milano EG, Capelli C, Wray J, Biffi B, Layton S, Lee M, Caputo M,
Taylor AM, Schievano S, Biglino G. Current and future applications of
3D printing in congenital cardiology and cardiac surgery. Br J Radiol.
2019 Feb;92(1094):20180389.
- Seddio F, Reddy VM, McElhinney DB, Tworetzky W, Silverman NH, Hanley
FL. Multiple ventricular septal defects: how and when should they be
repaired? J Thorac Cardiovasc Surg. 1999 Jan;117(1):134-9
- Pedra CA, Pedra SR, Chaccur P, Jatene M, Costa RN, Hijazi ZM, Amin Z.
Periventricular device closure of congenital muscular ventricular
septal defects. Expert Rev Cardiovasc Ther. 2010 May;8(5):663-74.
- Kumar TK, Knott-Craig CJ. Rare life-threatening complication of device
closure of ventricular septal defect in a child. J Thorac Cardiovasc
Surg. 2016 May;151(5):e85-6.
- Kitagawa T, Durham LA 3rd, Mosca RS, Bove EL. Techniques and results
in the management of multiple ventricular septal defects. J Thorac
Cardiovasc Surg. 1998 Apr;115(4):848-56.